
By Kamal Choudhury and Christy Santhosh
(Reuters) -The U.S. Food and Drug Administration on Thursday approved Kura Oncology and Japanese partner Kyowa Kirin's once-daily pill, Komzifti, to treat a rare form of blood cancer that has returned or stopped responding to treatment.
The drug is approved for acute myeloid leukemia patients with an NPM1 mutation, a genetic change found in about 30% of cases.
Acute myeloid leukemia is an aggressive cancer of the blood and bone marrow.
Kura said the drug will be available within the next few business days at a price of $48,500 for a one-month supply.
With the approval, Kura's drug now competes with Syndax Pharmaceuticals' Revuforj, which was approved for the same indication by the FDA last month.
Komzifti’s approval comes with a boxed warning for differentiation syndrome and an additional warning for QTc interval prolongation, a delay in the heart’s electrical recovery after a beat, and potential harm to unborn babies.
A boxed warning is the U.S. Food and Drug Administration’s strongest alert for serious or life-threatening risks and appears prominently on a drug’s label to warn doctors and patients.
Revuforj carries a boxed warning for QTc interval prolongation, giving Kura “a significant competitive advantage,” according to Wedbush analysts.
Kura's Chief Medical Officer Mollie Leoni said the risk of QTc prolongation with Komzifti is low, adding it is “extraordinarily unlikely” to lead to a boxed warning.
The company said it is in dialogue with the FDA about potential steps post-approval that could help refine the labeling.
Under the terms of its collaboration with Kyowa, Kura is responsible for manufacturing Komzifti and will lead commercialization in the United States, while Kyowa handles commercial strategy and development outside the U.S.
Analysts, on average, expect Komzifti to have annual sales of $1.32 billion by 2031, according to LSEG data.
(Reporting by Kamal Choudhury and Christy Santhosh in Bengaluru; Editing by Shailesh Kuber and Tasim Zahid)
latest_posts
- 1
The most effective method to Guarantee Simple Availability in Seniors' SUVs - 2
Far-right German youth group delegates seek deportations, remigration - 3
What is Fusarium graminearum, the fungus a Chinese scientist pleaded guilty to smuggling into the US? - 4
Monetary Security: Building Serious areas of strength for an Establishment - 5
Find the Interesting Universe of Computerized reasoning: the Capability of man-made intelligence
Gaza receiving over 70,000 cubic meters of water per day, COGAT claims
The most effective method to Arrange a Higher Medical caretaker Pay During Your Next New employee screening
Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
Stop the ‘good’ vs ‘bad’ snap judgments and watch your world become more interesting
Florence's Uffizi Gallery moves treasures to safety after cyberattack
The Most Compelling Innovation Developments Somewhat recently
NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
Israel, Gulf states report fresh missile and drone attacks
The Best Internet Mastering Stages for Expertise Improvement













